Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 22;11(15):2186.
doi: 10.3390/foods11152186.

Olive Pomace Oil versus High Oleic Sunflower Oil and Sunflower Oil: A Comparative Study in Healthy and Cardiovascular Risk Humans

Affiliations

Olive Pomace Oil versus High Oleic Sunflower Oil and Sunflower Oil: A Comparative Study in Healthy and Cardiovascular Risk Humans

Susana González-Rámila et al. Foods. .

Abstract

Olive pomace oil (OPO) is mainly a source of monounsaturated fat together with a wide variety of bioactive compounds, such as triterpenic acids and dialcohols, squalene, tocopherols, sterols and aliphatic fatty alcohols. To date, two long-term intervention studies have evaluated OPO’s health effects in comparison with high oleic sunflower oil (HOSO, study-1) and sunflower oil (SO, study-2) in healthy and cardiovascular risk subjects. The present study integrates the health effects observed with the three oils. Two randomized, blinded, cross-over controlled clinical trials were carried out in 65 normocholesterolemic and 67 moderately hypercholesterolemic subjects. Each study lasted fourteen weeks, with two four-week intervention phases (OPO versus HOSO or SO), each preceded by a three-week run-in or washout period. Regular OPO consumption reduced total cholesterol (p = 0.017) and LDL cholesterol (p = 0.018) levels as well as waist circumference (p = 0.026), and only within the healthy group did malondialdehyde (p = 0.004) levels decrease after OPO intake versus HOSO. Contrarily, after the SO intervention, apolipoprotein (Apo) B (p < 0.001) and Apo B/Apo A ratio (p < 0.001) increased, and to a lower extent Apo B increased with OPO. There were no differences between the study groups. OPO intake may improve cardiometabolic risk, particularly through reducing cholesterol-related parameters and waist circumference in healthy and hypercholesterolemic subjects.

Keywords: anthropometric parameters; clinical trial; high oleic sunflower oil; lipid peroxidation; lipid profile; olive pomace oil; sunflower oil.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Study design. The arrows indicate the visits performed.
Figure 2
Figure 2
Values represent the rate of change calculated from [(post-treatment value − pre-treatment value)/pre-treatment value] and the error bars represent standard error of mean (both expressed as percentage). n per group: normocholesterolemic: Olive pomace oil (OPO): n = 65, high oleic sunflower oil (HOSO): n = 34, sunflower oil (SO): n = 31; hypercholesterolemic: OPO: n = 67, HOSO: n = 30, SO: n = 37. According to the linear mixed model, the oil effect was significant: (A) p = 0.017; (B) p = 0.018; (C) p < 0.001; (D) p < 0.001. There were no significant differences between the study groups, neither oil × group interaction (p > 0.05). Apo: apolipoprotein.

Similar articles

Cited by

References

    1. Aranceta J., Pérez-Rodrigo C. Recommended dietary reference intakes, nutritional goals and dietary guidelines for fat and fatty acids: A systematic review. Br. J. Nutr. 2012;107:S8–S22. doi: 10.1017/S0007114512001444. - DOI - PubMed
    1. Julibert A., Bibiloni M.D.M., Mateos D., Angullo E., Tur J.A. Dietary fat intake and metabolic syndrome in older adults. Nutrients. 2019;11:1901. doi: 10.3390/nu11081901. - DOI - PMC - PubMed
    1. Guasch-Ferré M., Hu F.B., Martínez-González M.A., Fitó M., Bulló M., Estruch R., Ros E., Corella D., Recondo J., Gómez-Gracia E., et al. Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED Study. BMC Med. 2014;12:78. doi: 10.1186/1741-7015-12-78. - DOI - PMC - PubMed
    1. Beulen Y., Martínez-González M.A., Van de Rest O., Salas-Salvadó J., Sorlí J.V., Gómez-Gracia E., Fiol M., Estruch R., Santos-Lozano J.M., Schröder H., et al. Quality of dietary fat intake and body weight and obesity in a Mediterranean population: Secondary analyses within the PREDIMED trial. Nutrients. 2018;10:2011. doi: 10.3390/nu10122011. - DOI - PMC - PubMed
    1. Nocella C., Cammisotto V., Fianchini L., D’Amico A., Novo M., Castellani V., Stefanini L., Violi F., Carnevale R. Extra virgin olive oil and cardiovascular diseases: Benefits for human health. Endoc. Metab. Immune Disord. Drug Targets. 2018;18:4–13. doi: 10.2174/1871530317666171114121533. - DOI - PubMed

LinkOut - more resources